Congress widens scrutiny of meningitis outbreak

Your Health Matters

A security guard looks out from the front doors of pharmaceutical compounding company NECC, a producer of the steroid methylprednisolone acetate, in Framingham, MassachusettsWASHINGTON (Reuters) – Lawmakers on Friday widened their investigation into the deadly meningitis outbreak to include the role state regulators played in monitoring the pharmacy that produced steroid treatments blamed for killing 14 people in six states. The U.S. House of Representatives' Energy and Commerce Committee called on the Massachusetts pharmacy board to tell congressional staff what it knew about the New England Compounding Center before the recall of more than 17,000 vials of injectable steroid treatments for back and joint pain from health facilities in 23 states. …

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave